Skip to main content
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial The Lancet, Respiratory Medicine Kalil, A. 2021